SCHEMBL19786313

SCHEMBL19786313

c1ccc(-c2nc(-c3cccc4ccccc34)nc(-n3c4ccccc4c4c5c6ccc7ccccc7c6sc5c5ccccc5c43)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.36
CYP1B1 Q16678 2/20 0.36
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
NFKB1 P19838 1/20 0.34
MAPK1 P28482 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
ATM Q13315 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19786315 0.94 CYP1A1 (0.37) CYP1A1CYP1B1MAPTSMN1; SMN2CYP1A2
SCHEMBL19786558 0.91 CYP1A1 (0.35) CYP1A1CYP1B1KDM4EALDH1A1TP53
SCHEMBL21708955 0.88 CYP1A1 (0.36) CYP1A1CYP1B1KDM4EALDH1A1TP53
SCHEMBL15126935 0.85 CYP1A1 (0.37) CYP1A1CYP1B1MAPTSMN1; SMN2CYP1A2
SCHEMBL14951513 0.85 S1PR5 (0.35) KDM4EALDH1A1TP53SMN1; SMN2HSD17B10
SCHEMBL19786557 0.84 CYP1A1 (0.36) CYP1A1CYP1B1MAPTSMN1; SMN2CYP1A2
SCHEMBL18086357 0.84 KDM4E (0.34) KDM4EALDH1A1TP53MAPTHPGD
SCHEMBL17990880 0.84 CYP1A1 (0.39) CYP1A1CYP1B1KDM4EALDH1A1TP53
SCHEMBL25502236 0.82 KDM4E (0.35) KDM4EALDH1A1TP53MAPTHPGD
SCHEMBL23172248 0.82 CYP1A1 (0.38) CYP1A1CYP1B1MAPTSMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-10-03 US disclosed
WO-2018012781-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, OR51E2, ORAI2 CYP1A1 3556/4885CYP1B1 4207/4885KDM4E 442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.